NEC OncoImmunity AS and Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 Using Artificial Intelligence

NEC OncoImmunity AS (NOI), a subsidiary of NEC Corporation (NEC), and Oslo University Hospital (OUH) are pleased to announce that they have recently been awarded a prestigious grant from the Research Council of Norway (RCN) to develop an artificial intelligence (AI) platform that will enable the rapid design of T-cell diagnostics for emerging or endemic infectious diseases. The project will develop a novel T-cell diagnostic for the current COVID-19 pandemic to complement the current serological tests. This will improve the ability to identify immune responses and acquired immunity, which is desperately needed to deal with the COVID-19 crisis.

Current technologies involve extensive trial and error to define exactly which parts of the pathogen induces robust immunity. These so-called immunodominant epitopes need to be identified for the general population. These demanding, work-intensive and time-consuming steps are necessary to develop tests to monitor the T-cell response to viruses such as SARS-CoV-2 (the

Read More

Aortic Valve Market to Grow with Double Digit Growth Rate in Coming Years: P&S Intelligence

NEW YORK, Sept. 29, 2020 /PRNewswire/ — Muir Health says that valvular diseases, such as aortic stenosis, are detected in 1.5 million people in the U.S. every year. Therefore, due to the rising incidence of such valvular diseases, the global aortic valve market is predicted to witness a high CAGR of 13.2% between 2020 and 2030. At this rate, the industry size will increase from $7,568.3 million in 2019 to $29,146.9 million by 2030, according to the market research report published by P&S Intelligence.

P_and_S_Intelligence_Logo
P_and_S_Intelligence_Logo

Another such disease, the rising prevalence of which is driving the aortic valve market, is aortic regurgitation, as it requires valve replacement. The key reason behind the growing cases of such health conditions is the geriatric population, which is predicted to reach 1.5 billion by 2050, from 703 million in 2019, as per the UN. Further, rheumatic heart disease (RHD), which almost 33 million

Read More

Hospital Bed Market to Surpass $8,276.7 Million Revenue by 2030: P&S Intelligence

NEW YORK, Sept. 28, 2020 /PRNewswire/ —  Around the world, cases of cardiovascular diseases (CVDs), cancer, diabetes, and an array of other chronic and acute diseases are increasing. This is expected to drive the global hospital bed market from $3,712.1 million in 2019 to $8,276.7 million by 2030, at a 7.5% CAGR between 2020 and 2030, according to P&S Intelligence. All these diseases and a lot of other health issues result in hospitalization, with the number of hospitalized patients increasing rapidly.

P_and_S_Intelligence
P_and_S_Intelligence

This is the primary reason behind the hospital bed market advance, as even a more basic requirement in such medical settings than the expensive medical devices are beds! Many diseases, even a simple rhinovirus infection (common cold), make people weak enough to not be able to stand or sit, which makes laying them down necessary.

Get the sample copy of this report at @ https://www.psmarketresearch.com/market-analysis/hospital-beds-market/report-sample

The COVID-19

Read More